Skip to main content

The Pathogenesis of Hypertension in Obese Subjects

Drugs volume 46, pages 197–209 (1993)Cite this article

Summary

Obese subjects are at an increased risk of becoming hypertensive and vice versa.

Essential hypertension and obesity are commonly accompanied by insulin resistance (defined as impaired insulin-mediated glucose disposal) and hyperinsulinaemia. In the offspring of patients with essential hypertension, insulin resistance and hyperinsulinaemia, as well as related increases in serum low density lipoproteins and triglycerides, often occur prior to the development of essential hypertension, overweight or central redistribution of body fat. Moreover, once obesity, and in particular central obesity, is present, insulin resistance is more marked in hypertensive than in normotensive obese subjects. Hyperinsulinaemia and/or insulin resistance in turn promote body fat deposition and impaired glucose tolerance. This cycle helps to explain why a familial predisposition to essential hypertension poses an increased risk of developing not only hypertension but also dyslipidaemia, obesity and non-insulin-dependent (type 2) diabetes. It is still unclear whether insulin resistance and/or hyperinsulinaemia also promote hypertension per se.

Regardless of insulin’s exact pathogenic role, obesity and/or a high dietary intake of carbohydrates, salt, etc. can induce several potential pressor mechanisms: 1) higher plasma noradrenaline (norepinephrine) and adrenaline (epinephrine) levels, suggesting a higher sympathetic tone in obese than in nonobese subjects, and in hypertensive obese than in normotensive obese subjects; 2) similarly, a tendency to hyperaldosteronism, with largely normal plasma renin activity, in obese hypertensive patients; 3) enhanced sensitivity of blood pressure to salt; 4) increased total blood volume (although it is normal relative to body surface area), leading to increased cardiac output and eventually eccentric left ventricular hypertrophy; and 5) increased cytosolic free Ca++ levels and reduced intracellular Mg++ levels in the blood cells of obese hypertensive patients and patients with non-insulin-dependent diabetes, although this finding cannot necessarily be extrapolated to cationic levels in vascular muscle cells. Total peripheral vascular resistance is usually low in normotensive obese subjects and rises with the development of hypertension; compared with lean patients with essential hypertension, obese hypertensive patients tend to have a slightly lower level of total peripheral vasoconstriction and a slightly higher cardiac output.

Considering the intimate association between essential hypertension and obesity, as well as the prevalence and prognostic relevance of this combination, the spectrum of accompanying metabolic and cardiovascular abnormalities deserves careful consideration in the evaluation of therapeutic care for such patients.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 49.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  • Allemann Y, Horber FF, Colombo M, Ferrari P, Shaw S, et al. Decreased insulin sensitivity in normotensive offspring of hypertensive parents precedes gain or redistribution of body fat. Lancet 341: 327–331, 1993

    PubMed  CAS  Google Scholar 

  • Anderson EA, Balon TW, Hoffman RP, Sinkey CA, Mark AL; Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension 19: 621–627, 1992

    PubMed  CAS  Google Scholar 

  • Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hy-perinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. Journal of Clinical Investigation 87: 2246–2252, 1991

    PubMed  CAS  Google Scholar 

  • Aviv A. The roles of cell Ca2+, protein kinase C and the Na+-H+ antiport in the development of hypertension and insulin resistance. Journal of the American Society of Nephrology 3: 1049–1063, 1992

    PubMed  CAS  Google Scholar 

  • Bianchetti MG, Beretta-Piccoli C, Weidmann P, Ferner CF. Blood pressure control in normotensive members of hypertensive families. Kidney International 29: 882–888, 1986

    PubMed  CAS  Google Scholar 

  • Bianchi G, Cusi D, Ferrari P, Barlassina C, Pati P, et al. Renal abnormalities at the prehypertensive stage of essential hypertension Journal of Cardiovascular Pharmacology 12: S43–S48, 1988

    PubMed  Google Scholar 

  • Blaustein MP. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis American Journal of Physiology 232: C165–C173, 1977

    PubMed  CAS  Google Scholar 

  • Boehringer K, Beretta-Piccoli C, Weidmann P, Meier A, Ziegler W, et al. Pressor factors and cardiovascular pressor responsiveness in lean and overweight normal or hypertensive subjects. Hypertension 4: 697–702, 1982

    PubMed  CAS  Google Scholar 

  • Brenner BM, Garcia D, Anderson S. Glomeruli and blood pressure Less of one, more the other? American Journal of Hypertension 1: 335–347, 1988

    CAS  Google Scholar 

  • Campese VM, Romoff MS, Levitan D, Saglikes Y, Friedler RM, et al. Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney International 21: 371–378, 1982

    PubMed  CAS  Google Scholar 

  • Carretta R, Fabris B, Fischetti F, Costantini M, De Biasi F, et al. Reduction of blood pressure in obese hyperinsulinaemic hyperten-. sive patients during somatostatin infusion Journal of Hypertension 7: S196–S197, 1989

    PubMed  CAS  Google Scholar 

  • De Fronzo RA. The effect of insulin on renal sodium metabolism. Diabetologia 21: 165–171, 1981

    Google Scholar 

  • De Wardener HE, MacGregor GA. Dahl’s hypothesis that a saluretic substance may be responsible for a sustained raise in arterial pressure: its possible role in essential hypertension. Kidney International 18: 1–9, 1980

    PubMed  Google Scholar 

  • Denker PS, Pollock VE. Fasting serum insulin levels in essential hypertension. A meta-analysis. Archives of Internal Medicine 152: 1649–1651, 1992

    PubMed  CAS  Google Scholar 

  • Egan B, Panis R, Hinderliter A, Schork N, Julius S. Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. Journal of Clinical Investigation 80: 812–817, 1987

    PubMed  CAS  Google Scholar 

  • Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension 19: 403–418, 1992

    PubMed  CAS  Google Scholar 

  • Esler MD, Hasking J, Willet JR, Leonard PW, Jennings GL. Nor-adrenaline release and sympathetic nervous system activity. Journal of Hypertension 3: 117–129, 1985

    PubMed  CAS  Google Scholar 

  • Facchini F, Chen YD, Clinkingbeard C, Jeppesen J, Reaven GM. Insulin resistance, hyperinsulinemia, and dyslipidemia in non-obese individuals with a family history of hypertension. American Journal of Hypertension 5: 694–699, 1992

    PubMed  CAS  Google Scholar 

  • Felig P, Cunningham J, Levitt M, Hendler R, Nadel E. Energy expenditure in obesity in fasting and postprandial state American Journal of Physiology 244: E45–E51, 1983

    PubMed  CAS  Google Scholar 

  • Ferrannini E. The haemodynamics of obesity: a theoretical analysis. Journal of Hypertension 10: 1417–1423, 1992

    PubMed  CAS  Google Scholar 

  • Ferrannini E, Buzzigoli G, Giorico MA, Oleggini M, Graziadei L, et al. Insulin resistance in essential hypertension. New England Journal of Medicine 317: 350–357, 1987

    PubMed  CAS  Google Scholar 

  • Ferrannini E, De Fronzo RA. The association of hypertension, diabetes, and obesity: a review. Journal of Nephrology 1: 3–15, 1989

    Google Scholar 

  • Ferrari P, Weidmann P. Insulin, insulin sensitivity and hypertension. Journal of Hypertension 8: 491–500, 1990

    PubMed  CAS  Google Scholar 

  • Ferrari P, Weidmann P, Shaw SG, Giachino D, Riesen W, et al. Altered insulin sensitivity, hyperinsulinemia and dyslipidemia in individuals with a hypertensive parent. American Journal of Medicine 91: 589–596, 1991

    PubMed  CAS  Google Scholar 

  • Folkow B. Cardiovascular structural adaptation; its role in the initiation and maintenance of primary hypertension Clinical Science 55: 3S–22S, 1978

    Google Scholar 

  • Fujita T, Henry WL, Bartter FC, Lake CR, Delea CS. Factors influencing blood pressure in salt-sensitive patients with hypertension. American Journal of Medicine 69: 334–344, 1980

    PubMed  CAS  Google Scholar 

  • Gans ROB, Bilo HJG, Nauta JJP, Heine RJ, Donker AJM. Acute hyperinsulinemia induces sodium retention and a blood pressure decline in diabetes mellitus. Hypertension 20: 199–209, 1992

    PubMed  CAS  Google Scholar 

  • Gans ROB, Bilo HJG, van Maarschalkerweerd WWA, Heine RJ, Nauta JJP, et al. Exogenous insulin augments in healthy volunteers the cardiovascular reactivity to noradrenaline but not to angiotensin 11. Journal of Clinical Investigation 88: 512–517, 1991a

    PubMed  CAS  Google Scholar 

  • Gans ROB, Vandertoorn L, Bilo HJG, Nauta JJP, Heine RJ, et al. Renal and cardiovascular effects of exogenous insulin in healthy volunteers. Clinical Science 80: 219–225, 1991b

    PubMed  CAS  Google Scholar 

  • Giugliano D, Quatraro A, Consoli G, Minei A, Ceriello A, et al. Met-formin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors. European Journal of Clinical Pharmacology 44: 107–112, 1993

    PubMed  CAS  Google Scholar 

  • Goldstein DS. Plasma catecholamines and essential hypertension. Hypertension 5: 86–99, 1983

    PubMed  CAS  Google Scholar 

  • Gustafson AB, Kalkhoff RK. Influence of sex and obesity on plasma catecholamine response to isometric exercise. Journal of Clinical Endocrinology and Metabolism 55: 703–708, 1982

    PubMed  CAS  Google Scholar 

  • Guyton AC, Coleman TG, Cowley Jr AW, Schell KW, Manning Jr RD, et al. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and hypertension American Journal of Medicine 52: 584, 1972

    PubMed  CAS  Google Scholar 

  • Halkin H, Modan M, Shefi M, Almog S. Altered erythrocyte and plasma sodium and potassium in hypertension, a facet of hyperinsulinemia. Hypertension 11: 71–77, 1988

    PubMed  CAS  Google Scholar 

  • Istfan NW, Plaisted CS, Bistrian BR, Blackburn GL. Insulin resistance versus insulin secretion in the hypertension of obesity. Hypertension 19: 385–392, 1992

    PubMed  CAS  Google Scholar 

  • Jacobs DB, Sowers JR, Hmeidan A, Niyogi T, Simpson L, et al. Effects of weight reduction on cellular cation metabolism and vascular resistance. Hypertension 21: 308–314, 1993

    PubMed  CAS  Google Scholar 

  • Julius S, Gudrabrandsson T; Jamerson K, Andersson O. The interconnection between sympathetics, microcirculation, and insulin resistance in hypertension. Blood Pressure 1: 9–19, 1992

    PubMed  CAS  Google Scholar 

  • Jung RT, Shetty PS, Barrand MA, Callingham BA, James WPT. Role of catecholamines in hypertensive response to dieting. British Medical Journal 1: 12–13, 1979

    PubMed  CAS  Google Scholar 

  • Jung RT, Shetty PS, James WPT, Barrand MA, Callingham BA. Plasma catecholamines and autonomie responsiveness in obesity. International Journal of Obesity 6: 131–141, 1982

    PubMed  CAS  Google Scholar 

  • Kissebah AH, Peiris AN. Biology of regional body fat distribution: relationship to noninsulin dependent diabetes mellitus. Diabetes Metabolism Reviews 5: 83–89, 1989

    PubMed  CAS  Google Scholar 

  • Koolen Ml, van Brummelen P. Adrenergic activity and peripheral hemodynamics in relation to sodium sensitivity in patients with essential hypertension. Hypertension 6: 820–825, 1984

    PubMed  CAS  Google Scholar 

  • Koren MJ, Deveraux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Annals of Internal Medicine 114: 345–352, 1991

    PubMed  CAS  Google Scholar 

  • Kush RD, Young JB, Katzeff HL, Danforth Jr E, Garrow JS, et al. Effect of diet on energy expenditure and plasma norepinephrine in lean and obese Pima Indians. Metabolism 35: 1110–1120, 1986

    PubMed  CAS  Google Scholar 

  • Laakso M, Edelman SV, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. Journal of Clinical Investigation 85: 1844–1852, 1990

    PubMed  CAS  Google Scholar 

  • Landin K, Tengborn L, Smith U. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. Journal of Internal Medicine 229: 181–187, 1991

    PubMed  CAS  Google Scholar 

  • Landsberg L. Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermoge-nesis. Quarterly Journal of Medicine 236: 1081–1090, 1986

    Google Scholar 

  • Lauer MS, Anderson KM, Kannel WB, Levy D. The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. Journal of the American Medical Association 266: 231–236, 1991

    PubMed  CAS  Google Scholar 

  • Lee JC, Downing JE. Effects of insulin on cardiac muscle contraction and responsiveness to norepinephrine. American Journal of Physiology 230: 1360–1365, 1976

    PubMed  CAS  Google Scholar 

  • Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left-ventricular mass in the Framingham study. New England Journal of Medicine 322: 1561–1566, 1990

    PubMed  CAS  Google Scholar 

  • Levy J, Zemel MB, Sowers JR. Role of cellular calcium metabolism in abnormal glucose metabolism and diabetic hypertension. American Journal of Medicine 87 (Suppl. 6A): 7S–16S, 1989

    PubMed  CAS  Google Scholar 

  • Licata G, Scaglione R, Barbagallo M, Parrinello G, Capuana G, et al. Effect of obesity on left ventricular function studied by radionuclide angiocardiography. International Journal of Obesity 15: 295–302, 1991

    PubMed  CAS  Google Scholar 

  • Luke RG. Essential hypertension: a renal disease? Hypertension 21: 380–390, 1993

    PubMed  CAS  Google Scholar 

  • Marks P, Wilson B, Delassalle A. Aldosterone studies in obese patients with hypertension. American Journal of Medical Science 289: 224–228, 1985

    CAS  Google Scholar 

  • Mathias CJ, da Costa DF, Fosbraey P, Christensen NJ, Bannister R. Hypotensive and sedative effects of insulin in autonomie failure. British Medical Journal 295: 161–163, 1987

    PubMed  CAS  Google Scholar 

  • McMurray Jr RW, Vesely DL. Weight reduction decreases atrial natri-uretic factor and blood pressure in obese patients. Metabolism 38: 1231–1237, 1989

    PubMed  Google Scholar 

  • Messerli FH. Cardiovascular effects of obesity and hypertension. Lancet 1: 1165–1168, 1982

    PubMed  CAS  Google Scholar 

  • Messerli FH, Christie B, DeCarvalho GR, Aristimuno GG, Suarez DH, et al. Obesity and essential hypertension. Archives of Internal Medicine 141: 81–85, 1981

    PubMed  CAS  Google Scholar 

  • Messerli FH, Sundgaard-Riise K, Reisin E, et al. Disparate cardiovascular effects of obesity and arterial hypertension. American Journal of Medicine 74: 808–812, 1983

    PubMed  CAS  Google Scholar 

  • Messerli FH, Ventura HO, Reisin E, Dreslinski GR, Dunn FG, et al. Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation 66: 55–60, 1982

    PubMed  CAS  Google Scholar 

  • Modan M, Halkin H, Almog S, Lusky A, Eshkol A, et al. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. Journal of Clinical Investigation 75: 809–817, 1985

    PubMed  CAS  Google Scholar 

  • Mujais SK, Tarazi RC, Dustan HP, Fouard FM, Bravo EL. Hypertension in obese patients: hemodynamic and volume studies. Hypertension 4: 84–92, 1982

    PubMed  CAS  Google Scholar 

  • Natali A, Santoro D, Palombo C, Cerri M, Ghione S, et al. Impaired insulin action on skeletal muscle metabolism in essential hypertension. Hypertension 17: 170–178, 1991

    PubMed  CAS  Google Scholar 

  • O’Hare JA, Minaker K, Young JB, Rowe JW, Pallotta JA, et al. Insulin increases plasma norepinephrine (NE) and lowers plasma potassium equally in lean and obese men. (Abstract) Clinical Research 33: 441A, 1985

    Google Scholar 

  • Peiris AN, Sothmann MS, Hoffmann RG, Hennes MI, Wilson CR, et al. Adiposity, fat distribution, and cardiovascular risk. Annals of Internal Medicine 110: 867–872, 1989

    PubMed  CAS  Google Scholar 

  • Pfeifle B, Ditschuneit H. Effect of insulin on growth of cultured human arterial smooth muscle cells. Diabetologia 20: 155–158, 1981

    PubMed  CAS  Google Scholar 

  • Phillip T, Distler A, Cordes U. Sympathetic nervous system and blood-pressure control in essential hypertension Lancet 2: 959, 1978

    Google Scholar 

  • Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 39: 167–174, 1990

    PubMed  CAS  Google Scholar 

  • Reaven GM. Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease. American Heart Journal 121: 1283–1288, 1991

    PubMed  CAS  Google Scholar 

  • Reaven GM, Ho H, Hoffman BB. Somatostatin inhibition of fructoseinduced hypertension. Hypertension 14: 117–120, 1989

    PubMed  CAS  Google Scholar 

  • Reisin E, Frohlich ED, Messerli FH, Dreslinski GR, Dunn FG, et al. Cardiovascular changes after weight reduction in obesity hypertension. Annals of Internal Medicine 98: 315–319, 1983

    PubMed  CAS  Google Scholar 

  • Resnick LM, Gupta RK, Bhargava KK, Gruenspan H, Alderman MH, et al. Cellular ions in hypertension, diabetes, and obesity: A nuclear magnetic resonance spectroscopic study. Hypertension 17: 951–957, 1991

    PubMed  CAS  Google Scholar 

  • Rocchini AP. Cardiovascular regulation in obesity-induced hypertension. Hypertension 19 (Suppl. 1): 156–160, 1992

    Google Scholar 

  • Rocchini AP, Katch VL, Grekin R, Moorehead C, Anderson J. Role for aldosterone in blood pressure regulation of obese adolescents. American Journal of Cardiology 57: 613–618, 1986

    PubMed  CAS  Google Scholar 

  • Rocchini AP, Katch V, Kveselis D, Moorehead C, Martin M, et-al. Insulin and renal sodium retention in obese adolescents. Hypertension 14: 367–374, 1989a

    PubMed  CAS  Google Scholar 

  • Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. New England Journal of Medicine 321: 580–585, 1989b

    PubMed  CAS  Google Scholar 

  • Rocchini AP, Moorehead C, Katch V, Key J, Finta KM. Forearm resistance vessel abnormalities and insulin resistance in obese adolescents. Hypertension 19: 615–620, 1992

    PubMed  CAS  Google Scholar 

  • Rooney DP, Edgar JD, Sheridan B, Atkinson AB, Bell PM. The effect of low dose insulin infusions on the renin angiotensin and sympathetic nervous system in normal man. European Journal of Clinical Investigation 21: 430–435, 1991

    PubMed  CAS  Google Scholar 

  • Schwartz RS, Halter JB, Bierman EL. Reduced thermic effect of feeding in obesity: role of norepinephrine. Metabolism 32: 114–117, 1983

    PubMed  CAS  Google Scholar 

  • Sharma AM, Ruland K, Spies KP, Distler A. Salt sensitivity in young normotensive subjects is associated with a hyperinsulinemic response to oral glucose. Journal of Hypertension 9: 329–335, 1991

    PubMed  CAS  Google Scholar 

  • Sharma AM, Schorr U, Distler A. Insulin resistance in- young saltsensitive normotensive subjects. Hypertension 21: 273–279, 1993

    PubMed  CAS  Google Scholar 

  • Shaw S, Allemann Y, Ferrari P, Wey J, Piso RJ, et al. Erythrocyte cation content and transport systems in normotensive members of hypertensive families. Cardiovascular Risk Factors 2: 393–403, 1992

    Google Scholar 

  • Shen DC, Shieh SM, Fun MMT, Wu DA, Chen YDI, et al. Resistance to insulin stimulated glucose uptake in patients with hypertension. Journal of Clinical Endocrinology and Metabolism 66: 580–583, 1988

    PubMed  CAS  Google Scholar 

  • Skrabal F, Herholz H, Neumayr M, Hamberger L, Ledochowski M, et al. Salt sensitivity in humans is linked to enhanced sympathetic responsiveness and to enhanced proximal tubular reabsorption. Hypertension 6: 152–158, 1984

    PubMed  CAS  Google Scholar 

  • Sowers JR. Relationship between hypertension and subtle and overt abnormalities of carbohydrate metabolism Journal of the American Society of Nephrology 1: S39–S47, 1990

    PubMed  CAS  Google Scholar 

  • Sowers JR, Nyby M, Stern N, Beck F, Baron S, et al. Blood pressure and hormone changes associated with weight reduction in the obese. Hypertension 4: 686–691, 1982a

    PubMed  CAS  Google Scholar 

  • Sowers JR, Whitfield LA, Beck FW, Catania RA, Tuck ML, et al. Role of enhanced sympathetic nervous system activity and reduced Na+,K+-dependent adenosine triphosphatase activity in maintenance of elevated blood pressure m obesity: effects of weight loss Clinical Science 63: 121S–124S, 1982b

    Google Scholar 

  • Sowers JR, Whitfield LA, Catania RA, Stern N, Tuck ML, et al. Role of the sympathetic nervous system in blood pressure maintenance in obesity. Journal of Clinical Endocrinology and Metabolism 54: 1181–1186, 1982c

    PubMed  CAS  Google Scholar 

  • Stamler R, Stamler J, Riedlinger WF, Algera G, Roberts RH. Weight and blood pressure: findings in hypertension screening of 1 million Americans. Journal of the American Medical Association 240: 1607–1610, 1978

    PubMed  CAS  Google Scholar 

  • Stout RW, Bierman El, Ross R. The effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circulation Research 36: 319–327, 1975

    PubMed  CAS  Google Scholar 

  • Tedde R, Sechi LA, Marigliano A, Pala A, Scano L. Antihypertensive effect of insulin reduction in diabetic-hypertensive patients. American Journal of Hypertension 2: 163–170, 1989

    PubMed  CAS  Google Scholar 

  • Townsend RR, Yamamoto R, Nickols M, DiPette DJ, Nickols GA. Insulin enhances pressor responses to norepinephrine in rat mes-entericvasculature. Hypertension 19 (Suppl. 11): 11–105–11–110, 1992

    Google Scholar 

  • Troisi RJ, Weiss ST, Parker DR, Sparrow D, Young JB, et al. Relation of obesity and diet to sympathetic nervous system activity. Hypertension 17: 669–677, 1991

    PubMed  CAS  Google Scholar 

  • Troisi RJ, Weiss ST, Segal MR, Cassaro PA, Vokonas PS, et al. The relationship of body fat distribution to blood pressure in normotensive men: the normative aging study. International Journal of Obesity 14: 515–525, 1990

    PubMed  CAS  Google Scholar 

  • Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. New England Journal of Medicine 304: 930–933, 1981

    PubMed  CAS  Google Scholar 

  • Tuck ML, Sowers, JR, Dornfield L, Withfield L, Maxwell M. Reductions in plasma catecholamines and blood pressure during weight loss in obese subjects. Acta Endocrinologica 102: 252–257, 1983

    PubMed  CAS  Google Scholar 

  • Weder AB. Red-cell lithium-sodium countertransport and renal lithium clearance in hypertension. New England Journal of Medicine 314: 198–201, 1986

    PubMed  CAS  Google Scholar 

  • Weidmann P. Recent pathogenetic aspects in essential hypertension and hypertension associated with diabetes mellitus. Klinische Wochenschrift 58: 1071–1089, 1980

    PubMed  CAS  Google Scholar 

  • Weidmann P. Pathogenetic and therapeutic relevance of cardiovascular pressor reactivity to norepinephrine in human hypertension. Clinical and Experimental Hypertension All (Suppl. 1): 257–273, 1989

  • Weidmann P, Beretta-Piccoli C, Trost BN. Pressor factors and responsiveness in hypertension accompanying diabetes mellitus. Hypertension 7 (Suppl. II): 33–42, 1987

    Google Scholar 

  • Weidmann P, Beretta-Piccoli C, Ziegler WH, Keusch G, Glück Z. Age versus urinary sodium for judging renin, aldosterone and cate-cholamine levels. Studies in normal subjects and patients with essential hypertension. Kidney International 14: 619–628, 1978

    PubMed  CAS  Google Scholar 

  • Weidmann P, Boehlen LM, de Courten M. Insulinresistenz, Hyper-insulinamie und Hypertonie. Münchner Medizinische Wochenschrift 134: 782–786, 1992

    Google Scholar 

  • Weidmann P, Boehlen LM, de Courten M. Pathogenesis and treatment of hypertension associated with diabetes mellitus. American Heart Journal 125: 1498–1513, 1993a

    PubMed  CAS  Google Scholar 

  • Weidmann P, de Courten M, Bohlen L. Insulin resistance, hyperinsulinemia and hypertension. Journal of Hypertension, in press, 1993b

  • Weidmann P, Ferrari P. Hypertension in the diabetic: central role of sodium. Diabetes Care 14: 220–232, 1991

    PubMed  CAS  Google Scholar 

  • Weinsier RL, James LD, Darnell BE, Dustan HP, Birch R, et al. Obesity-related hypertension: evaluation of the separate effects of energy restriction and weight reduction on hemodynamic and neuroendo-crine status. American Journal of Medicine 90: 460–468, 1991

    PubMed  CAS  Google Scholar 

  • Welle S, Campbell RG. Stimulation of thermogenesis by carbohydrate overfeeding. Journal of Clinical Investigation 71: 916–925, 1983

    PubMed  CAS  Google Scholar 

  • Widgren BR, Herlitz H, Aurell M, Berglund G, Wikstrand J, et al. Increased systemic and renal sensitivity to angiotensin II in normotensive men with positive family histories of hypertension. American Journal of Hypertension 5: 167–174, 1992

    PubMed  CAS  Google Scholar 

  • Widgren BR, Herlitz H, Berglund G, Wikstrand J, Jonsson O, et al. Normotensive young men with family histories of hypertension gain weight and decrease their intraerythrocyte sodium content during 5-year follow-up. Journal of Internal Medicine 229: 217–223, 1991

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Universitätspoliklinik, Freiburgstrasse 3, 3010, Bern, Switzerland

    Peter Weidmann, Maximilian de Courten, Lorenz Boehlen & Sidney Shaw

Authors
  1. Peter Weidmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maximilian de Courten
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lorenz Boehlen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sidney Shaw
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Weidmann, P., de Courten, M., Boehlen, L. et al. The Pathogenesis of Hypertension in Obese Subjects. Drugs 46 (Suppl 2), 197–209 (1993). https://doi.org/10.2165/00003495-199300462-00030

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199300462-00030

Keywords

  • Obesity
  • Insulin Resistance
  • Essential Hypertension
  • Obese Subject
  • Sympathetic Nervous System Activity